Results 91 to 100 of about 20,082,992 (152)

Mutation of rearranged during transfection (RET) is associated with enhanced tumor immunogenicity and favorable outcomes in pan-cancer immunotherapy. [PDF]

Oncologist
Cai J, Huang Z, Li Y, Zhou J, Xu Y, Cai M, Zhao H, Zhao B.   +7 more
europepmc   +1 more source

Identification of Actionable Gene Variants in Pulmonary Large-Cell Neuroendocrine Carcinoma: A Real-World Analysis of a Polish Cohort. [PDF]

Int J Mol Sci
Szpechcinski A, Pelc M, Lechowicz U, Szolkowska M, Moes-Sosnowska J, Rudzinski P, Wojda E, Skronska P, Podgorska E, Maszkowska-Kopij K, Polaczek M, Orlowski T, Langfort R, Chorostowska-Wynimko J.   +13 more
europepmc   +1 more source

Diagnostic Utility of a Cost-Effective Four-Gene Next Generation Sequencing Panel for Predicting Papillary Thyroid Carcinoma in Indeterminate Thyroid Cytology: A Multicenter Study in China. [PDF]

Cancer Med
Jiao Q, Wu L, Wei B, Li Q, Su X, Sun K, Zhang X, Luo Y, Liu Z.   +8 more
europepmc   +1 more source

The combination of pralsetinib and bevacizumab enhances antitumor activity against KIF5B-RET lung cancer via PI3K/AKT pathway. [PDF]

J Thorac Dis
Wang X, Yuan G, Cong L, Song Z, Lin L, Cao Z.   +5 more
europepmc   +1 more source

Hepatocyte BPGM Induces RET Lactylation and Macrophage Reprogramming to Promote Tumorigenesis in Hepatocellular Carcinoma. [PDF]

Adv Sci (Weinh)
Zhang J, Shi L, Lin L, Zhang Y, Zhang M, Wu L, Xia Y, Zhang Y, Han P, Zhuang L, Zhuang L, Shi L.   +11 more
europepmc   +1 more source

Medullary thyroid carcinoma exclusively associated with a homozygous RET V778I pathogenic variant: a case report with review of literature. [PDF]

Endocr J
Kihara M, Miyauchi A, Akamizu T.
europepmc   +1 more source

<i>RET</i> fusion partners dictate oncogenic potential in undifferentiated spindle cell sarcomas. [PDF]

Cancer Biol Ther
Gui Q, Zhang Y, Yang M, Liang R, Huang M, Yang X, Chen N, Chen X, Wu M, Chen H, Meng L, Xiao S, Tao M.   +12 more
europepmc   +1 more source

Modern therapeutic approaches in cholangiocarcinoma: A narrative review of key biomarkers and clinical trials. [PDF]

Transl Oncol
Almeida A, Manzi J, Hoff C, Kadri H, Livingstone A, Gleisner A, Toegel EB, Schulick R, Hoff PM, Vianna R, Abreu P.   +10 more
europepmc   +1 more source

Targeted therapies in the management of advanced medullary thyroid cancer. [PDF]

Oncologist
Arain HA, Izhar A, Caretti R, Chen H, Vodopivec DM.   +4 more
europepmc   +1 more source

Combination of Selpercatinib and Trametinib Overcomes Resistance to RET Inhibitors in RET-Mutant Medullary Thyroid Carcinoma. [PDF]

JCO Precis Oncol
Milewski D, Fallatah A, Groff M, Rahmy A, Khan SR, Okafor C, Glassberg B, Chou HC, Heselmeyer-Haddad K, Wangsa D, Wangsa D, Kim Y, Isanogle K, Song Y, Zhang X, Thomas C, Difilippantonio S, Park JI, Wei JS, Hawley RG, Glod J, Khan J.   +21 more
europepmc   +1 more source